Publicaciones en las que colabora con Josep Antoni Ramos-Quiroga (34)

2023

  1. CLINICAL VIEW ON SUBSTANCE-INDUCED PSYCHOTIC SYMPTOMS IN A MEDICALLY SUPERVISED INJECTING ROOM: A DECADE OF EXPERIENCE

    Actas espanolas de psiquiatria, Vol. 51, Núm. 4, pp. 188-191

  2. Clinical features and factors related to lifetime suicidal ideation and suicide attempts in patients who have had substance-induced psychosis across their lifetime

    Psychiatry Research, Vol. 323

2022

  1. Confirmatory factor analysis of 20-item toronto alexithymia scale in spanish patients with substance use disorder

    Actas espanolas de psiquiatria, Vol. 50, Núm. 5, pp. 208-215

2021

  1. Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life

    Frontiers in Psychiatry, Vol. 12

  2. Is alexithymia related to retention and relapses in patients with substance use disorders?: A one year follow-up study

    Addictive Behaviors, Vol. 113

  3. Psychiatric Comorbidity and Addiction Severity Differences in Patients With ADHD Seeking Treatment for Cannabis or Cocaine Use Disorders

    Journal of Attention Disorders, Vol. 25, Núm. 7, pp. 978-988

  4. Treatment retention and abstinence of patients with substance use disorders according to addiction severity and psychiatry comorbidity: A six-month follow-up study in an outpatient unit

    Addictive Behaviors, Vol. 117

2020

  1. Corrigendum to “Evaluation of previous substance dependence genome-wide significant findings in a Spanish sample” (Drug and Alcohol Dependence (2018) 187 (358–362), (S0376871618302096), (10.1016/j.drugalcdep.2018.03.013))

    Drug and Alcohol Dependence

  2. Insomnia Symptoms in Patients With Substance Use Disorders During Detoxification and Associated Clinical Features

    Frontiers in Psychiatry, Vol. 11

2019

  1. ADGRL3 (LPHN3) variants predict substance use disorder

    Translational Psychiatry, Vol. 9, Núm. 1

  2. Cocaine-Induced Psychosis and Asenapine as Treatment: A Case Study

    Psychopharmacology bulletin, Vol. 49, Núm. 1, pp. 92-97

2018

  1. Alcohol use disorder and cognitive impairment in old age patients: A 6 months follow-up study in an outpatient unit in Barcelona

    Psychiatry Research, Vol. 261, pp. 361-366

  2. Benzodiazepine use disorder and cognitive impairment in older patients: A six-month-follow-up study in an outpatient unit in Barcelona

    Journal of Studies on Alcohol and Drugs, Vol. 79, Núm. 6, pp. 844-852

  3. Evaluation of previous substance dependence genome-wide significant findings in a Spanish sample

    Drug and Alcohol Dependence, Vol. 187, pp. 358-362

  4. Sex differences in an old adult sample with substance use disorder: A 6 months follow-up study

    Psychiatry Research, Vol. 270, pp. 1157-1165

2017

  1. Association of the PLCB1 gene with drug dependence

    Scientific Reports, Vol. 7, Núm. 1

2015

  1. Criteria and Concurrent Validity of Adult ADHD Section of the Psychiatry Research Interview for Substance and Mental Disorders

    Journal of Attention Disorders, Vol. 19, Núm. 12, pp. 999-1006

2014

  1. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: Results of the IASP study

    Addiction, Vol. 109, Núm. 2, pp. 262-272

  2. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: Results from an international multi-center study exploring DSM-IV and DSM-5 criteria

    Drug and Alcohol Dependence, Vol. 134, Núm. 1, pp. 158-166

2013

  1. Association study of 37 genes related to serotonin and dopamine neurotransmission and neurotrophic factors in cocaine dependence

    Genes, Brain and Behavior, Vol. 12, Núm. 1, pp. 39-46